Derek Lowe

Biotech, healthcare, tech
Derek Lowe
Biotech, healthcare, tech
Contributor since: 2007
Another Alzheimer's IPO
Biogen's Bad Week
The Incomplete Response Letter
Alnylam Sues Dicerna
Four Patients. Count 'Em, Four.
More On Axovant's IPO
Some Side Effect For An Antibody
Piling On Andrew Witty
How Not To Handle Your Clinical Data
Sanofi Bets On Schrödinger
Biogen's Alzheimer's Data
Merck Strips Out Cubist
All That Cash
More Price Hikes On Obscure Medication
A Look At Actavis
AbbVie Competes On Price
AbbVie Competes On Price
A Slight Cubist Complication
Kickbacks At Sanofi?
Amgen Claims It All
Sanofi Beats The Drum
Bind's Attempts To Remake Chemotherapy